Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pemetrexed.php on line 2
Pemetrexed
LE WE PMID CA
Pemetrexed4377Pemetrexed

Bortezomib ttProteasom

Cetuximab ttEGFR

Lung and bronchial system (Neoplasia)

Mesothelioma

Pemetrexed

2007  
1
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation.
[17181984] Health Technol Assess 11(1): 1-90 (2007)
2007  
2
Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications.
[17308042] Mol Cancer Ther 6(2): 404-17 (2007)
2000  
3
Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.
[11106124] Ann Oncol 11(10): 1335-41 (2000)
2003  
4
Review of a promising new agent--pemetrexed disodium.
[12673697] Cancer 97(8 Suppl): 2056-63 (2003)
2004  
5
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.
[15217974] Clin Cancer Res 10(12 Pt 2): 4276s-4280s (2004)
2009  
6
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.
[19221167] Oncologist 14(3): 253-63 (2009)
2004  
7
FDA drug approval summaries: pemetrexed (Alimta).
[15477632] Oncologist 9(5): 482-8 (2004)
2001  
8
Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.
[11524555] Oncologist 6(4): 363-73 (2001)
2005  
9
Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab.
[15821248] Oncologist 10(4): 282-91 (2005)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pemetrexed.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pemetrexed.php on line 92